Single-Use Assemblies Market Trends: How Biopharmaceutical Manufacturing Is Embracing Disposable Technologies
The
single-use assemblies market supports biopharmaceutical and pharmaceutical
production with pre-sterilized, disposable components such as bags, filters,
tubes, and connectors. Polaris Market Research reports that the market was
valued at USD 14.88 billion in 2025 and is projected to reach USD 58.83 billion
by 2034, growing at a CAGR of 16.5% from 2026 to 2034, with a 2026 market
estimate of USD 16.32 billion. For operations and sourcing teams, performance
depends not only on product design but also on supply reliability, outsourcing
relationships, and process compatibility. This article focuses on those
practical considerations.
Tubing Assemblies and Other Supporting Formats
Bag assemblies and filtration assemblies receive most of the
attention in the product segmentation, which also includes bottle assemblies, tubing
assemblies, and other formats. According to the report, bottle assemblies
and tubing assemblies contribute to market growth through applications
in storage, transfer, and process fluid management, although their growth is
more niche compared with the two dominant segments. Even so, tubing
assemblies remain essential connectors between unit operations, and buyers
evaluating a complete single-use train should treat them as a core design
decision rather than an afterthought.
Fluid Transfer Assemblies in Practice
Thermo Fisher Scientific Inc. offers a range of single-use
assemblies for bioprocessing applications, including fluid transfer
assemblies, 2D and 3D BioProcess Containers, and bioprocess drum liners and
accessories. According to the report, these solutions minimize the risk of
cross-contamination, reduce cleaning requirements, and accelerate
implementation timelines. Fluid transfer assemblies illustrate how
single-use design shortens setup and removes the need for cleaning and
validation that traditional multi-use equipment demands.
Sartorius Stedim Biotech S.A. offers the Sartocon
Self-contained Filter Loop Assembly and the Sartocon Slice Self-contained Bag
Loop Assembly, both integrating polyethersulfone membranes. These sterile,
gamma-sterilized assemblies are pre-wetted and flushed, reducing setup time,
and their fully enclosed design supports safe purification of biologics such as
vaccines and recombinant proteins in cGMP environments.
Medical-Grade Polymer Supply and Raw Material Risk
The reliability of single-use systems depends heavily on the
international supply chain for specialized polymer-based raw materials. As
demand for biological products, vaccines, and advanced therapeutics rises,
manufacturers face added pressure to source high-quality inputs. The report
notes that disruptions in the global supply chain, logistics problems,
geopolitical factors, and medical-grade polymer shortages can affect
production timelines for single-use products.
To mitigate these risks, material providers will need to
increase manufacturing capability, develop infrastructure to supply raw
materials on a regional basis, and strengthen sourcing activities. For buyers,
consistent access to medical-grade polymer supply is a practical
qualification criterion when selecting assembly vendors.
CROs and CMOs: The Fastest-Growing End-User Group
By end user, biopharmaceutical and pharmaceutical companies
hold the largest share, at 58.6% in 2025. However, CROs and CMOs are
experiencing the fastest growth, supported by the growing trend of outsourcing
in the pharmaceutical industry. These organizations need flexible and scalable
manufacturing solutions to accommodate various projects and clients, and they
benefit from reduced setup and cleaning times that allow faster project
turnaround and cost savings. Growing demand for biopharmaceutical outsourcing
services further accelerates adoption of single-use assemblies among CROs
and CMOs.
ππ«π¨π°π¬π ππ¨π«π
ππ§π¬π’π π‘ππ¬:
https://www.polarismarketresearch.com/industry-analysis/single-use-assemblies-market
Sterile Bioprocessing Trends
Polaris Market Research highlights several trends shaping sterile
bioprocessing. These include a sustainability focus on environmentally
friendly, recyclable, and biodegradable single-use products; integration of
digital technologies such as real-time monitoring, automation, and data
analytics; growing demand for customization and flexibility; and a shift toward
modular and scalable manufacturing systems. Advancements in digital
technologies are also becoming integrated into single-use systems, providing
competitive advantages for companies that invest in them.
Regional Perspective
North America held the largest share, at 37.4% in 2025,
supported by major biopharmaceutical companies, robust healthcare
infrastructure, and strong regulatory support for biopharmaceutical
manufacturing. Asia Pacific is projected to grow at a CAGR of 17.4%, driven by
expanding manufacturing capabilities in China and India, where lower
manufacturing costs and large-scale production capabilities are attracting
local and global pharmaceutical companies. In Europe, countries such as
Germany, the UK, and Switzerland are key players in the pharmaceutical sector,
and European Medicines Agency guidelines drive demand for reliable and sterile
manufacturing processes.
Competitive Strategy and Key Players
Key players identified in the report include Thermo Fisher
Scientific Inc.; Sartorius Stedim Biotech S.A.; GE Healthcare Life Sciences;
Merck KGaA, Darmstadt, Germany; Danaher Corporation; Pall Corporation;
Eppendorf AG; Saint-Gobain Performance Plastics; Bio-Rad Laboratories, Inc.;
Lonza Group; Repligen Corporation; Waters Corporation; 3M Company; Becton,
Dickinson and Company; and Koch Membrane Systems, Inc. Partnerships and
collaborations are described as key strategies for market penetration, with some
players working alongside contract manufacturers to expand their offerings. New
entrants are advised to focus on innovative product design, environmentally
sustainable materials, digital integration, and customizable solutions for
niche applications.
Conclusion
As the
single-use assemblies market advances toward USD 58.83 billion by 2034,
success will depend on more than component quality. Dependable medical-grade
polymer supply, well-designed tubing assemblies and fluid
transfer assemblies, close alignment with CROs and CMOs, and
continued innovation in sterile bioprocessing will shape which suppliers
earn long-term trust from biopharmaceutical manufacturers.
More Trending Latest Reports By Polaris Market Research:
Building
Information Modeling Market
Unmanned
Electronic Warfare Market
Comments
Post a Comment